EsoBiotec

EsoBiotec is developing a technological platform for the in vivo engineering of T-cells and other immune effector cells to generate cell therapies, such as CARs and TCRs, inside the body of patients for the treatment of cancer.

  • CEO and Founder: Jean-Pierre Latere
  • CSO: Philippe Parone
  • Location: Belgium
  • Web: esobiotec.com